Firms have assisted parties involved in learning solutions provider MPS North America’s 100% acquisition of US-based Unbound Medicine in a deal valued at USD16.5 million.
Cyril Amarchand Mangaldas acted as principal counsel to MPS, a public company listed on the BSE and NSE, and its wholly owned subsidiary MPS North America.
The acquisition was completed under a stock purchase agreement signed between NYSE-listed Unbound Medicine, MPS North America, Unbound Medicine founder and CEO William Detmer and certain company shareholders.
Partner Mohit Gogia led the CAM transaction team, with the assistance of senior associate Anisha Dash, as well as associates Muskaan Garg, Swathi Kathi, Avikalp Mishra and Yash Kataria.
For MPS North America, Cadwalader, Wickersham & Taft was US counsel, Ernst & Young acted as financial adviser and USAIndiaCFO was the tax adviser.
District Capital Partners acted as banker to Unbound Medicine and Cooley was US counsel.
Unbound Medicine is engaged in the healthcare and medical information technology sector. MPS is a leading global provider of platforms, content and learning solutions, now operating as a listed Indian company serving global enterprises, publishers and learning organisations in India with offices in Europe and the US. Its subsidiary MPS North America provides editorial, design and digital publishing services in the US.
